Partnering to Innovate in Rare Disease

Innovation has been in our DNA for more than a century. Our teams are relentlessly driving advances across immunoglobulins, immunology, haematology, cardiovascular, and renal disease.  In each of these areas, our commitment to patients is unwavering, fuelled by a belief that the next breakthrough might come from anywhere, or anyone.  That’s why we place such a high value on external innovation - working closely with organizations outside our walls that have unique technologies, assets and equipment to help address patients’ unmet needs around the globe.

Our Approach

At CSL, we bring more than just funding to the table. Underpinned by a true collaborative spirit, we offer global infrastructure, deep expertise in product and clinical development and commercialization, and a proven ability to scale and deliver therapies worldwide. 

For our partners, this means access to resources that can turn ideas into real-world impact. Whether you’re a start-up with a promising asset or a mature company seeking to expand your reach, CSL is uniquely positioned to help you fast-track  your progress. Our doors are open to new ideas, new partnerships, and new ways of working that can deliver the next generation of therapies faster, further, and for more people in need.

We leverage innovative approaches to meet the diverse needs of biotechs